Vimarsana
Biggest News Aggregation in the World

Page 37 - Alex Sinclair News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alex Sinclair. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alex Sinclair Today - Breaking & Trending Today

IIH headaches could be treated with exenatide - Vimarsana News

IIH headaches could be treated with exenatide

The type 2 diabetes therapy is being tested on patients in a phase 2 clinical trial - News - PharmaTimes

Medicine Used To Treat Type 2 Diabetes Might Heal Blinding IIH Headaches: Study - Vimarsana News

Medicine Used To Treat Type 2 Diabetes Might Heal Blinding IIH Headaches: Study

The researchers reveal that this is a major trial for the rare and debilitating condition IIH that can lead to people going blind and suffering disabling daily headaches.

Source: india.com
New medicine to lower brain pressure might treat blinding IIH headaches: Study - Vimarsana News

New medicine to lower brain pressure might treat blinding IIH headaches: Study

A new experiment has discovered that patients suffering from 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) might be treated with an injectable peptide used to treat type 2 diabetes.

Health News | New Medicine to Lower Brain Pressure Might Treat Blinding IIH Headaches: Study - Vimarsana News

Health News | New Medicine to Lower Brain Pressure Might Treat Blinding IIH Headaches: Study

Get latest articles and stories on Health at LatestLY. A new experiment has discovered that patients suffering from 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) might be treated with an injectable peptide used to treat type 2 diabetes. Health News | New Medicine to Lower Brain Pressure Might Treat Blinding IIH Headaches: Study.

Injectable peptide rapidly reduces intracranial pressure - Vimarsana News

Injectable peptide rapidly reduces intracranial pressure

A study for idiopathic intercranial hypertension is the first to show rapid and a major reduction in brain pressure and monthly headaches.